Veterinary Medicines

VITAMIN-E-SELEN ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ

Authorised
  • Sodium selenite pentahydrate
  • DL-ALPHA TOCOPHEROL ACETATE
Download as PDF

Product identification

Medicine name:
VITAMIN-E-SELEN ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • Sodium selenite pentahydrate
  • DL-ALPHA TOCOPHEROL ACETATE
Target species:
  • Cattle
  • Equid
  • Pig
  • Goat
  • Sheep
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Sodium selenite pentahydrate
    1.67
    milligram(s)
    /
    1.00
    millilitre(s)
  • DL-ALPHA TOCOPHEROL ACETATE
    150.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal, milk
        0
        day
      • Liver
        7
        day
    • Equid
      • Meat and offal, milk
        0
        day
      • Liver
        7
        day
    • Pig
      • Meat and offal
        0
        day
      • Liver
        7
        day
    • Goat
      • Meat and offal, milk
        0
        day
      • Liver
        7
        day
    • Sheep
      • Meat and offal, milk
        0
        day
      • Liver
        7
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal, milk
        0
        day
      • Liver
        7
        day
    • Equid
      • Meat and offal, milk
        0
        day
      • Liver
        7
        day
    • Pig
      • Meat and offal
        0
        day
      • Liver
        7
        day
    • Goat
      • Meat and offal, milk
        0
        day
      • Liver
        7
        day
    • Sheep
      • Meat and offal, milk
        0
        day
      • Liver
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CE99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Richter Pharma AG
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 30439/K2175/04-12-1985/K-0018701
Date of authorisation status change: